This study is to determine the safety and immunogenicity of envelope recombinant proteins in infants who are indeterminate HIV status born to HIV-infected women. It will also evaluate changes in viral load in infants proven to be infected and absolute CD4 counts in all immunized children.
Showing the most recent 10 out of 211 publications